Federal Supply Schedule 36F79724D004E
Award Date
12/17/23
Last Date to Order
6/14/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
Agepha Pharma USA LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, with a ceiling value of $2,225,000.00, is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB.
The contract has a period of performance from June 15, 2021 to June 14, 2026. As an FSS contract, it allows for the placement of task orders by federal agencies for the...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025.
This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025.
The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs (VA) to Apotex Corp. for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $23,375,390.00 and a period of performance from September 15, 2024 to September 14, 2029.
As a Federal Supply Schedule contract, this is a multiple award vehicle that allows federal agencies to directly purchase the awarded products and services. The contract...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024.
As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Ascend Therapeutics US LLC, a foreign-owned for-profit organization. The $25,000 interim agreement is under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance through September 14, 2023. As a multiple award contract, this FSS provides the VA with a pre-negotiated list of products and services that can be ordered as needed. The scope...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Health Administration (VHA) to Avyxa Pharma, LLC, a for-profit limited liability company. The contract is for drug, pharmaceutical, and hematology-related products under FSS Schedule 65 I B. It is a multiple award with a total ceiling value of $25,000. The period of performance runs from the award date of November 15, 2024 to the ultimate completion date of May 14, 2025. As an FSS contract, this is an indefinite...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Royal Pharmaceuticals LLC, a foreign-owned for-profit organization. The contract, valued at up to $750,000.00, is for the provision of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule.
The contract has an ultimate completion date of September 30, 2025 and was awarded on October 1, 2019. It is a multiple-award contract, meaning there...